Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nithya Ramnath

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Scientific Reports|July 24, 2015
A Novel Serum 4-microRNA Signature for Lung Cancer DetectionErnest Nadal, Anna Truini, Asuka Nakata, et al.
World Journal of Clinical Oncology|October 16, 2015
Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancerMichael Mix, Nithya Ramnath, Jorge Gomez, et al.
Leukemia Research|February 3, 2009
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancerRamya Varadarajan, LaurieAnn Ford, Sheila N J Sait, et al.
JCO Oncology Practice|September 24, 2020
Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVIDCindy Y Jiang, Nadeem T El-Kouri, David Elliot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Epigenetic regulation of vitamin D metabolism in human lung adenocarcinomaNithya Ramnath, Ernest Nadal, Chae Kyung Jeon, et al.
Scientific Reports|May 31, 2022
Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancerAngel Qin, Fatima Lima, Samantha Bell, et al.
Biomarkers in Cancer|March 8, 2016
The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer MedicineLouis D Fiore, Mary T Brophy, Sara Turek, et al.
BMC Cancer|August 3, 2006
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancerJun Yang, Nithya Ramnath, Kirsten B Moysich, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 26, 2003
HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridizationDongfeng Tan, George Deeb, Jianmin Wang, et al.
Chest|May 8, 2013
Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesNithya Ramnath, Thomas J Dilling, Loren J Harris, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Scientific Reports|July 24, 2015
A Novel Serum 4-microRNA Signature for Lung Cancer DetectionErnest Nadal, Anna Truini, Asuka Nakata, et al.
World Journal of Clinical Oncology|October 16, 2015
Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancerMichael Mix, Nithya Ramnath, Jorge Gomez, et al.
Leukemia Research|February 3, 2009
Metachronous and synchronous presentation of acute myeloid leukemia and lung cancerRamya Varadarajan, LaurieAnn Ford, Sheila N J Sait, et al.
JCO Oncology Practice|September 24, 2020
Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVIDCindy Y Jiang, Nadeem T El-Kouri, David Elliot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Epigenetic regulation of vitamin D metabolism in human lung adenocarcinomaNithya Ramnath, Ernest Nadal, Chae Kyung Jeon, et al.
Scientific Reports|May 31, 2022
Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancerAngel Qin, Fatima Lima, Samantha Bell, et al.
Biomarkers in Cancer|March 8, 2016
The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer MedicineLouis D Fiore, Mary T Brophy, Sara Turek, et al.
BMC Cancer|August 3, 2006
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancerJun Yang, Nithya Ramnath, Kirsten B Moysich, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 26, 2003
HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridizationDongfeng Tan, George Deeb, Jianmin Wang, et al.
Chest|May 8, 2013
Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesNithya Ramnath, Thomas J Dilling, Loren J Harris, et al.
Pageof 15